Blue Trust Inc. Reduces Holdings in Humana Inc. (NYSE:HUM)

Blue Trust Inc. trimmed its stake in Humana Inc. (NYSE:HUM) by 10.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,314 shares of the insurance provider’s stock after selling 154 shares during the period. Blue Trust Inc.’s holdings in Humana were worth $333,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the stock. State Street Corp grew its position in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock valued at $1,701,582,000 after buying an additional 53,272 shares during the last quarter. FMR LLC grew its position in shares of Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after buying an additional 643,291 shares during the last quarter. Pzena Investment Management LLC grew its position in shares of Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after buying an additional 187,903 shares during the last quarter. Ontario Teachers Pension Plan Board grew its position in shares of Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after buying an additional 71,910 shares during the last quarter. Finally, Sanders Capital LLC grew its position in shares of Humana by 1.0% in the 3rd quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock valued at $370,060,000 after buying an additional 11,923 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Up 1.3 %

Shares of NYSE HUM opened at $257.24 on Wednesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The firm has a 50-day moving average price of $270.62 and a 200 day moving average price of $292.21. The stock has a market capitalization of $30.97 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts anticipate that Humana Inc. will post 16.11 EPS for the current fiscal year.

Analyst Ratings Changes

HUM has been the topic of several research reports. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. JPMorgan Chase & Co. lowered their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and raised their price objective for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average target price of $285.68.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.32% of the stock is currently owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.